Circulating levels of adipocyte and epidermal fatty acid-binding proteins in relation to nephropathy staging and macrovascular complications in type 2 diabetic patients.
about
Serum fatty acid-binding protein 4 is a predictor of cardiovascular events in end-stage renal diseaseSerum retinol-binding protein 4 as a marker for cardiovascular disease in womenAdipocyte fatty acid-binding protein modulates inflammatory responses in macrophages through a positive feedback loop involving c-Jun NH2-terminal kinases and activator protein-1.Contribution of serum adipocyte fatty acid-binding protein levels to the presence of microalbuminuria in a Chinese hyperglycemic population.Chronic administration of BMS309403 improves endothelial function in apolipoprotein E-deficient mice and in cultured human endothelial cells.Polymorphisms in fatty acid binding protein 5 show association with type 2 diabetesFatty Acid-Binding Protein 4 (FABP4): Pathophysiological Insights and Potent Clinical Biomarker of Metabolic and Cardiovascular Diseases.Positive correlation of serum adipocyte fatty acid binding protein levels with carotid-femoral pulse wave velocity in geriatric populationSmall lipid-binding proteins in regulating endothelial and vascular functions: focusing on adipocyte fatty acid binding protein and lipocalin-2.Cardiomyocyte Overexpression of FABP4 Aggravates Pressure Overload-Induced Heart Hypertrophy.Association Between Serum Levels of Adipocyte Fatty Acid-binding Protein and Free Thyroxine.Elevated circulating adipocyte-fatty acid binding protein levels predict incident cardiovascular events in a community-based cohort: a 12-year prospective study.Cytokine-like Activity of Liver Type Fatty Acid Binding Protein (L-FABP) Inducing Inflammatory Cytokine Interleukin-6.High Serum Adipocyte Fatty Acid Binding Protein Is Associated with Metabolic Syndrome in Patients with Type 2 Diabetes.Adiponectin and adipocyte fatty acid binding protein in the pathogenesis of cardiovascular disease.Adipose-Derived Fatty Acid-Binding Proteins Plasma Concentrations Are Increased in Breast Cancer Patients.Lipid chaperones and metabolic inflammation.Biomarkers of progression in diabetic nephropathy: The past, present and futurePost-weaning high-fat diet accelerates kidney injury, but not hypertension programmed by maternal diabetes.Serum adipocyte fatty acid-binding protein levels are associated with peripheral arterial disease in women, but not men, with type 2 diabetes mellitus.Overexpression of heart-type fatty acid binding protein enhances fatty acid-induced podocyte injury.Serum Adipocyte Fatty Acid-Binding Protein 4 Levels Are Independently Associated with Radioisotope Glomerular Filtration Rate in Type 2 Diabetic Patients with Early Diabetic Nephropathy.Circulating FABP4 is eliminated by the kidney via glomerular filtration followed by megalin-mediated reabsorptionSoluble cMet levels in urine are a significant prognostic biomarker for diabetic nephropathyPharmacological Inhibition of Fatty Acid-Binding Protein 4 (FABP4) Protects Against Rhabdomyolysis-Induced Acute Kidney Injury
P2860
Q28477907-22D73343-4745-4B46-BFB5-FC7A3028A8C1Q28484681-9ACBCDFA-9CBE-4A69-B140-C28994C1C5E6Q33795966-3BCE8DCD-FFD6-42BF-B5B9-49134B5C8BCCQ33871277-D101F476-7E6A-4B55-AC10-D22A21ED3C1DQ34672088-2EDD938B-4790-4D12-AADB-5F7F1C8EC1BFQ34809998-50D0EB2F-522D-4833-BD81-138F841888FBQ35042217-D192A11C-A916-415E-A8B2-38066225944FQ35709448-16E8FDD6-CBA9-4077-9F4B-B8ADEC00F392Q35859743-236E85E1-E1AE-4EC5-B9FF-2B6C2235E3C1Q36050356-28C1AE37-4B1F-45A7-9D3E-39B8C3B74B41Q36195508-B98760EF-15AE-42C2-A737-E7734EC51D93Q36701727-F6015833-C518-4A67-B0FC-25E9486E1826Q37378495-ABFF06C0-2039-45C1-A3C0-F443CF305FFDQ37497167-19D74442-E3F6-497A-8792-7917366D2516Q37972596-1D82E4BB-33BF-42C3-BC51-19EA9A5F7D93Q38682013-C170F4CE-9940-41BE-A778-7D7779A4252DQ38908903-C3D86D27-1F8D-4A09-A0C5-B8482B85697DQ39007369-00296982-0A51-4F6D-A3AA-D89C477C134CQ40318979-84363C52-1B67-4D19-8826-70204C39EDC1Q47824822-937172E5-C90D-4EE4-B977-CF13FB83FA7AQ50053918-3B783793-A55A-47BB-BC7A-A35D1CB4C844Q55476340-B895AE3A-0F3D-4842-A6AA-D608395E3C17Q58608864-A014082C-D01D-42EC-8066-B9D900317132Q58708114-E3945324-C980-4BF8-8B41-BAAB982202E2Q58795443-D4F17B07-A598-4856-B9FC-BBCF450AE30C
P2860
Circulating levels of adipocyte and epidermal fatty acid-binding proteins in relation to nephropathy staging and macrovascular complications in type 2 diabetic patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Circulating levels of adipocyt ...... s in type 2 diabetic patients.
@en
Circulating levels of adipocyt ...... s in type 2 diabetic patients.
@nl
type
label
Circulating levels of adipocyt ...... s in type 2 diabetic patients.
@en
Circulating levels of adipocyt ...... s in type 2 diabetic patients.
@nl
prefLabel
Circulating levels of adipocyt ...... s in type 2 diabetic patients.
@en
Circulating levels of adipocyt ...... s in type 2 diabetic patients.
@nl
P2093
P2860
P356
P1433
P1476
Circulating levels of adipocyt ...... s in type 2 diabetic patients.
@en
P2093
Annette W K Tso
Carol H Y Fong
Dennis C Y Yeung
Karen S L Lam
Nelson M S Wat
Pak C Sham
Sidney Tam
P2860
P304
P356
10.2337/DC08-1333
P407
P577
2008-10-17T00:00:00Z